Circular RNA-Related CeRNA Network and Prognostic Signature for Patients with Osteosarcoma

References

• Mirabello L, Zhu B, Koster R, et al. Frequency of pathogenic germline variants in cancer-susceptibility genes in patients with osteosarcoma. JAMA Oncol. 2020;6(5):724–734. doi:10.1001/jamaoncol.2020.019732191290
   PubMed Web of Science ®Google Scholar
• Matsuoka K, Bakiri L, Wolff LI, et al. Wnt signaling and Loxl2 promote aggressive osteosarcoma. Cell Res. 2020;30(10):885–901. doi:10.1038/s41422-020-0370-132686768
   PubMed Web of Science ®Google Scholar
• Davis LE, Bolejack V, Ryan CW, et al. Randomized double-blind phase II study of regorafenib in patients with metastatic osteosarcoma. J Clin Oncol. 2019;37(16):1424–1431. doi:10.1200/JCO.18.0237431013172
   PubMed Web of Science ®Google Scholar
• Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med. 1986;314(25):1600–1606. doi:10.1056/NEJM1986061931425023520317
   PubMed Web of Science ®Google Scholar
• Meyers PA, Healey JH, Chou AJ, et al. Addition of pamidronate to chemotherapy for the treatment of osteosarcoma. Cancer. 2011;117(8):1736–1744. doi:10.1002/cncr.2574421472721
   PubMed Web of Science ®Google Scholar
• Hasenfratz M, Mellert K, Marienfeld R, et al. Profiling of three H3F3A-mutated and denosumab-treated giant cell tumors of bone points to diverging pathways during progression and malignant transformation. Sci Rep. 2021;11(1):5709. doi:10.1038/s41598-021-85319-x33707617
   PubMed Web of Science ®Google Scholar
• Weglarz-Tomczak E, Rijlaarsdam DJ, Tomczak JM, Brul S. GEM-based metabolic profiling for human bone osteosarcoma under different glucose and glutamine availability. Int J Mol Sci. 2021;22(3):1470. doi:10.3390/ijms2203147033540580
   PubMed Web of Science ®Google Scholar
• Gao X, Xia X, Li F, et al. Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR-STAT3 signalling. Nat Cell Biol. 2021;23(3):278–291. doi:10.1038/s41556-021-00639-433664496
   PubMed Web of Science ®Google Scholar
• Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer. 2021;21(1):22–36. doi:10.1038/s41568-020-00306-033082563
   PubMed Web of Science ®Google Scholar
• Tang K, Zhang H, Li Y, Sun Q, Jin H. Circular RNA as a potential biomarker for melanoma: a systematic review. Front Cell Dev Biol. 2021;9:638548. doi:10.3389/fcell.2021.63854833869186
   PubMed Web of Science ®Google Scholar
• Jiang T, Xia Y, Lv J, et al. A novel protein encoded by circMAPK1 inhibits progression of gastric cancer by suppressing activation of MAPK signaling. Mol Cancer. 2021;20(1):66. doi:10.1186/s12943-021-01358-y33836754
   PubMed Web of Science ®Google Scholar
• Wu X, Xiao S, Zhang M, et al. A novel protein encoded by circular SMO RNA is essential for Hedgehog signaling activation and glioblastoma tumorigenicity. Genome Biol. 2021;22(1):33. doi:10.1186/s13059-020-02250-633446260
   PubMed Web of Science ®Google Scholar
• Shen S, Yao T, Xu Y, Zhang D, Fan S, Ma J. CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc. Mol Cancer. 2020;19(1):151. doi:10.1186/s12943-020-01269-433106166
   PubMed Web of Science ®Google Scholar
• Nie WB, Zhao LM, Guo R, Wang MX, Ye FG. Circular RNA circ-NT5C2 acts as a potential novel biomarker for prognosis of osteosarcoma. Eur Rev Med Pharmacol Sci. 2021;25(5):2154.33755943
   PubMed Web of Science ®Google Scholar
• Li Y, Shen R, Wang A, et al. Construction of a prognostic immune-related LncRNA risk model for lung adenocarcinoma. Front Cell Dev Biol. 2021;9:648806. doi:10.3389/fcell.2021.64880633869203
   PubMed Web of Science ®Google Scholar
• Tan Y, Sun R, Liu L, et al. Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-kappaB signaling to trigger pyroptosis in breast cancer. Theranostics. 2021;11(11):5214–5231. doi:10.7150/thno.5832233859743
   PubMed Web of Science ®Google Scholar
• Geng W, Lv Z, Fan J, et al. Identification of the prognostic significance of somatic mutation-derived LncRNA signatures of genomic instability in lung adenocarcinoma. Front Cell Dev Biol. 2021;9:657667. doi:10.3389/fcell.2021.65766733855028
   PubMed Web of Science ®Google Scholar
• Fuca G, Corti F, Ambrosini M, et al. Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors. J Immunother Cancer. 2021;9(4):e002501. doi:10.1136/jitc-2021-00250133849927
   PubMed Web of Science ®Google Scholar
• Hu Y, Zheng M, Wang S, et al. Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancer. Genomics. 2021;113(4):2134–2144. doi:10.1016/j.ygeno.2021.04.01233845140
   PubMed Web of Science ®Google Scholar
• Wu Y, Xie Z, Chen J, et al. Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression. Mol Cancer. 2019;18(1):73. doi:10.1186/s12943-019-1007-130940151
   PubMed Web of Science ®Google Scholar
• Gianferante DM, Mirabello L, Savage SA. Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy. Nat Rev Endocrinol. 2017;13(8):480–491. doi:10.1038/nrendo.2017.1628338660
   PubMed Web of Science ®Google Scholar
• Lin Z, Xie X, Lu S, Liu T. Noncoding RNAs in osteosarcoma: implications for drug resistance. Cancer Lett. 2021;504:91–103. doi:10.1016/j.canlet.2021.02.00733587978
   PubMed Web of Science ®Google Scholar
• Liu Y, Wu H, Jing J, Li H, Dong S, Meng Q. Downregulation of hsa_circ_0001836 induces pyroptosis cell death in glioma cells via epigenetically upregulating NLRP1. Front Oncol. 2021;11:622727. doi:10.3389/fonc.2021.62272733869006
   PubMed Web of Science ®Google Scholar
• Chen S, Yang X, Yu C, et al. The potential of circRNA as a novel diagnostic biomarker in cervical cancer. J Oncol. 2021;2021:5529486. doi:10.1155/2021/552948633880120
   PubMed Web of Science ®Google Scholar
• Chen Z, Xu W, Zhang D, et al. circCAMSAP1 promotes osteosarcoma progression and metastasis by sponging miR-145-5p and regulating FLI1 expression. Mol Ther Nucleic Acids. 2021;23:1120–1135. doi:10.1016/j.omtn.2020.12.01333664993
   PubMedGoogle Scholar
• Qiu Y, Pu C, Li Y, Qi B. Construction of a circRNA-miRNA-mRNA network based on competitive endogenous RNA reveals the function of circRNAs in osteosarcoma. Cancer Cell Int. 2020;20:48. doi:10.1186/s12935-020-1134-132063749
   PubMed Web of Science ®Google Scholar
• Liao YX, Yu HY, Lv JY, et al. Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma. Int J Oncol. 2019;55(6):1213–1222.31638211
   PubMed Web of Science ®Google Scholar
• Niu J, Yan T, Guo W, Wang W, Zhao Z. Insight into the role of autophagy in osteosarcoma and its therapeutic implication. Front Oncol. 2019;9:1232. doi:10.3389/fonc.2019.0123231803616
   PubMed Web of Science ®Google Scholar
• Zhang J, Yu XH, Yan YG, Wang C, Wang WJ. PI3K/Akt signaling in osteosarcoma. Clin Chim Acta. 2015;444:182–192. doi:10.1016/j.cca.2014.12.04125704303
   PubMed Web of Science ®Google Scholar
• Zhao GS, Gao ZR, Zhang Q, et al. TSSC3 promotes autophagy via inactivating the Src-mediated PI3K/Akt/mTOR pathway to suppress tumorigenesis and metastasis in osteosarcoma, and predicts a favorable prognosis. J Exp Clin Cancer Res. 2018;37(1):188. doi:10.1186/s13046-018-0856-630092789
   PubMed Web of Science ®Google Scholar
• Xue Y, Zhang G, Zhou S, et al. Iron chelator induces apoptosis in osteosarcoma cells by disrupting intracellular iron homeostasis and activating the MAPK pathway. Int J Mol Sci. 2021;22(13):7168. doi:10.3390/ijms2213716834281233
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu M, Liu W, Wang W. Ras-ERK1/2 signalling promotes the development of osteosarcoma through regulation of H4K12ac through HAT1. Artif Cells Nanomed Biotechnol. 2019;47(1):1207–1215. doi:10.1080/21691401.2019.159385730942624
   PubMed Web of Science ®Google Scholar
• Rubio R, Gutierrez-Aranda I, Saez-Castillo AI, et al. The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development. Oncogene. 2013;32(41):4970–4980. doi:10.1038/onc.2012.50723222711
   PubMed Web of Science ®Google Scholar
• Benslimane-Ahmim Z, Pereira J, Lokajczyk A, et al. Osteoprotegerin regulates cancer cell migration through SDF-1/CXCR4 axis and promotes tumour development by increasing neovascularization. Cancer Lett. 2017;395:11–19. doi:10.1016/j.canlet.2017.02.03228263839
   PubMed Web of Science ®Google Scholar
• Pignatelli J, LaLonde SE, LaLonde DP, Clarke D, Turner CE. Actopaxin (alpha-parvin) phosphorylation is required for matrix degradation and cancer cell invasion. J Biol Chem. 2012;287(44):37309–37320. doi:10.1074/jbc.M112.38522922955285
   PubMed Web of Science ®Google Scholar
• Ng L, Tung-Ping Poon R, Yau S, et al. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion. Hepatology. 2013;58(2):667–679. doi:10.1002/hep.2639623504997
   PubMed Web of Science ®Google Scholar
• Velazquez-Torres G, Shoshan E, Ivan C, et al. A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression. Nat Commun. 2018;9(1):461. doi:10.1038/s41467-018-02851-729386624
   PubMed Web of Science ®Google Scholar
• Yu H, Yu Z, Wang X, Wang D. Circular RNA circCLK3 promotes the progression of tongue squamous cell carcinoma via miR-455-5p/PARVA axis. Biotechnol Appl Biochem. 2021. doi:10.1002/bab.2120
   Web of Science ®Google Scholar
• Li DQ, Hou YF, Wu J, et al. Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis. Eur J Cancer. 2006;42(18):3274–3286. doi:10.1016/j.ejca.2006.07.00816979889
   PubMed Web of Science ®Google Scholar
• Ji X, Yang X, Wang N, et al. Function of SLC7A7 in T-cell acute lymphoblastic leukemia. Cell Physiol Biochem. 2018;48(2):731–740. doi:10.1159/00049189930025393
   PubMedGoogle Scholar
• Fan S, Meng D, Xu T, et al. Overexpression of SLC7A7 predicts poor progression-free and overall survival in patients with glioblastoma. Med Oncol. 2013;30(1):384. doi:10.1007/s12032-012-0384-823408368
   PubMed Web of Science ®Google Scholar
• Dai W, Feng J, Hu X, et al. SLC7A7 is a prognostic biomarker correlated with immune infiltrates in non-small cell lung cancer. Cancer Cell Int. 2021;21(1):106. doi:10.1186/s12935-021-01781-733632211
   PubMed Web of Science ®Google Scholar
• Tina E, Prosen S, Lennholm S, Gasparyan G, Lindberg M, Gothlin Eremo A. Expression profile of the amino acid transporters SLC7A5, SLC7A7, SLC7A8 and the enzyme TDO2 in basal cell carcinoma. Br J Dermatol. 2019;180(1):130–140. doi:10.1111/bjd.1690529938775
   PubMed Web of Science ®Google Scholar